Avoro Capital Advisors LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Avoro Capital Advisors LLC
- $8.3 Billion
- Q1 2024
A detailed history of Avoro Capital Advisors LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 8,555,555 shares of ARWR stock, worth $222 Million. This represents 2.95% of its overall portfolio holdings.
Number of Shares
8,555,555
Previous 1,130,000
657.13%
Holding current value
$222 Million
Previous $34.6 Million
607.64%
% of portfolio
2.95%
Previous 0.49%
Shares
7 transactions
Others Institutions Holding ARWR
# of Institutions
296Shares Held
88.5MCall Options Held
905KPut Options Held
387K-
Black Rock Inc. New York, NY15.3MShares$399 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$322 Million0.01% of portfolio
-
State Street Corp Boston, MA6.56MShares$171 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$108 Million2.38% of portfolio
-
Artal Group S.A. Luxembourg, N43.04MShares$78.9 Million4.68% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.75B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...